Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Filings indexed 1,080 across all filing types
Latest filing 2018-04-27 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
平安证券股份有限公司关于普莱柯生物工程股份有限公司2017年持续督导年度报告书
Audit Report / Information Classification · 95% confidence The document is titled as a "2017 年持续督导年度报告书" (2017 Annual Continuous Supervision Report) issued by Ping An Securities Co., Ltd. regarding the company 普莱柯生物工程股份有限公司. It references regulatory approvals, ongoing supervision activities, and compliance checks over the period 2015 to 2017. The document includes detailed descriptions of supervisory work, information disclosure reviews, and compliance with securities regulations. It is a comprehensive report on the continuous supervision activities by the sponsor institution rather than a financial report like an annual report or interim report. The document length is 6570 characters, which is substantial and contains detailed supervisory content, not just an announcement or certification. Therefore, it fits best under the category of Audit Report / Information (AR), as it is a standalone supervisory report related to regulatory compliance and ongoing monitoring, distinct from a full annual report (10-K) or other categories. FY 2017
2018-04-27 Chinese
董事会薪酬与考核委员会工作规则
Governance Information Classification · 95% confidence The document is titled '董事会薪酬与考核委员会工作规则' which translates to 'Board Remuneration and Assessment Committee Working Rules'. It details the structure, responsibilities, and procedures of the board's remuneration and assessment committee, including rules on compensation and performance evaluation of directors and senior management. There are no financial statements, earnings data, or regulatory filings. The content focuses on governance practices related to remuneration and assessment. This matches the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is 2632 characters, indicating it is a full document rather than a brief announcement. Therefore, the correct classification is CGR with high confidence.
2018-04-27 Chinese
募集资金年度存放与使用情况鉴证报告
Regulatory Filings
2018-04-27 Chinese
关于2017年度募集资金存放与实际使用情况的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the storage and actual use of funds raised by the company in 2017. It includes specifics about the amount raised, usage of funds, management of funds, investment projects, changes in investment projects, and compliance with regulatory requirements. It also contains auditor and sponsor opinions on the use of the raised funds. The document references regulatory guidelines and includes tables detailing the use and management of the raised capital. This type of document is typically classified as a Capital/Financing Update (CAP) because it focuses on the status and use of funds raised through financing activities rather than being a full annual report or audit report. The document length and detail confirm it is not a mere announcement of a report but a substantive update on capital usage.
2018-04-27 Chinese
关于续聘会计师事务所及其费用的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from the company about the reappointment of an accounting firm (立信会计师事务所) for auditing the 2018 financial report and internal control audit. It details the board's resolution, audit fees, and independent directors' opinions. The document does not contain the audit report itself or detailed financial statements but is a formal announcement regarding the audit engagement and fees. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information such as audit firm appointments and fees, excluding full annual reports. The document length is short and focused on audit appointment and fees, not a full annual report or financial statements. Therefore, the classification is AR with high confidence. FY 2017
2018-04-27 Chinese
关于召开2017年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2017 Annual General Meeting (AGM) of the company 普莱柯生物工程股份有限公司. It includes details such as the date, voting methods, meeting agenda, and instructions for shareholders to attend and vote. It does not contain the actual annual report or financial statements but rather informs shareholders about the meeting where such reports will be discussed and voted on. The document length is 3286 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2018-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.